Techniques in Vascular & Interventional Radiology
Volume 13, Issue 1 , Pages 59-63 , March 2010

Drug Eluting Balloons

  • Nicolas A. Diehm, MD

      Affiliations

    • Division of Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland
    • Corresponding Author InformationAddress reprint requests to Nicolas A. Diehm, MD, Swiss Cardiovascular Center, Clinical and Interventional Angiology, Inselspital, Bern University Hospital, Bern, Switzerland
    • ,
  • Hanno Hoppe, MD

      Affiliations

    • Department of Diagnostic and Interventional Radiology, Inselspital, Bern University Hospital, Bern, Switzerland
    • ,
  • Dai-Do Do, MD

      Affiliations

    • Division of Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland

References 

  1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5–S67
  2. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879–1888
  3. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–2749
  4. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653–662
  5. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331–338
  6. Minar E, Pokrajac B, Ahmadi R, et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: Pilot study. Radiology. 1998;208:173–179
  7. Johnston KW. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology. 1992;183:767–771
  8. Nikanorov A, Smouse HB, Osman K, et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg. 2008;48:435–440
  9. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312–315
  10. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther. 2007;14:241–250
  11. Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810–814
  12. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689–699
  13. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358–1365

PII: S1089-2516(09)00071-7

doi: 10.1053/j.tvir.2009.10.008

Techniques in Vascular & Interventional Radiology
Volume 13, Issue 1 , Pages 59-63 , March 2010

Article Tools

* Image Usage & Resolution